Ifa lose mazindol 2mg
Ifa lose mazindol 2mg Helps with obesity treatment and indicated as an aid in the treatment of exogenous obesity with a Body Mass Index (BMI)> 30 kg / m2. Or also overweight with a BMI> 27 kg / m2 with some associated comorbidity associated with a hypocaloric diet and exercise.
See also terfamex 30mg
mazindol brand name ?
In large pharmacies in Mexico you can find these brands:
Recognizing obesity as a health problem, different organizations around the world have allowed the use of mazindol to counteract it in the short term . However, experts do not recommend the use of mazindol for weight loss due to insufficient evidence of efficacy at 12 months in obese adults.
1 Box, 15 and also 30 Tablets, 1mg
1 Box, 15 and also 30 Tablets, 2 mg
Pharmacokinetics Ifa lose mazindol 2mg :
Studies related to tritium-labeled mazindol show that the salt is absorbed quantitatively at an intermediate rate from the gastrointestinal tract and that blood levels are directly proportional to the doses administered.
The concentration of mazindol in blood increases progressively until it reaches its maximum peak in approximately 2 to 4 hours, followed by a progressive decrease in drug concentrations.
Conjugated metabolites are produced in the liver, the main one circulating in human plasma is 2- (2-aminoethyl-3- (p-chlorophenyl) -3-hydroxyphthalomidine.
Studies carried out to establish the half-life of the same, by determining the speed of elimination from the blood, showed that the permanence was variable between 35 and 55 hours, in the same studies it was observed that the half-life of mazindol was prolonged due to its slow elimination through the urinary and fecal routes, three quarters of the administered dose, through the urinary route and a quarter through the feces.
IFA LOSE , an anorectic whose chemical composition, mechanism and site of action are totally different from those of amphetamines and their derivatives. The absence of the phenyl-ethyl-amine chain (characteristic of amphetamines and also their derivatives) eliminates IFA LOSE the risk of causing dependence and confers a greater margin of therapeutic safety.
IFA LOSE reduces the sensation of hunger, acting directly on the satiety center of the hypothalamus, inhibiting the reuptake of norepinephrine.
IFA LOSE makes it easier for obese patients to adapt to the prescribed diet, inducing a sensible and also sustained weight reduction.
According to the studies carried out, IFA LOSE does not induce dependence or tolerance to the recommended therapeutic doses.
side effects of Ifa lose mazindol 2mg?
If you experience any of the following serious side effects, stop taking Ifa Lose and also seek emergency medical attention:
•an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);
•an irregular heartbeat or very high blood pressure (severe headache, blurred vision); or
•hallucinations, abnormal behavior, or confusion.
Other, less serious side effects may be more likely to occur. Continue to take Ifa Lose and talk to your doctor if you experience
•dry mouth or an unpleasant taste in your mouth,
•diarrhea or constipation, or
•impotence or changes in your sex drive.
So You can become physically and psychologically dependent on this medication, and withdrawal effects may occur if you stop taking it suddenly after several weeks of continuous use. So Talk to your doctor about stopping this medication gradually.
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.